Luminopia, founded in 2015, is leveraging virtual reality (VR) technology to treat ocular disorders like amblyopia, with upcoming clinical trials planned at Boston Children's Hospital and the Southern School of Optometry. VR's ability to control visual stimuli in a precise manner fosters neuroplasticity, which can aid in treating both mechanical and non-mechanical eye disorders. The presentation also discusses the challenges and opportunities in using VR for medical applications, emphasizing the need for cost-effectiveness, ease of use, and proof of effectiveness through clinical trials.